Cryoablation Safer Than RF In Treating Atrial Fib, Trial Sponsor Says
This article was originally published in The Gray Sheet
Executive Summary
CryoCath expects to learn by April whether FDA will require a follow-up period of longer than six months for a pivotal study of the Arctic Front ablation catheter to treat chronic atrial fibrillation